FSMVX
Price
$28.42
Change
-$0.38 (-1.32%)
Updated
Jun 13 closing price
Net Assets
1.75B
JVMCX
Price
$25.82
Change
-$0.30 (-1.15%)
Updated
Jun 13 closing price
Net Assets
21.46B
Interact to see
Advertisement

FSMVX vs JVMCX

Header iconFSMVX vs JVMCX Comparison
Open Charts FSMVX vs JVMCXBanner chart's image
Fidelity Mid Cap Value
Price$28.42
Change-$0.38 (-1.32%)
VolumeN/A
Net Assets1.75B
JHancock Disciplined Value Mid Cap C
Price$25.82
Change-$0.30 (-1.15%)
VolumeN/A
Net Assets21.46B
FSMVX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMVX vs. JVMCX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMVX is a Buy and JVMCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. FSMVX (1.75B). FSMVX pays higher dividends than JVMCX: FSMVX (0.91) vs JVMCX (0.00). FSMVX was incepted earlier than JVMCX: FSMVX (24 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than FSMVX (0.83). FSMVX is a more actively managed with annual turnover of: 96.00 vs. JVMCX (47.00). FSMVX has a lower initial minimum investment than JVMCX: FSMVX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -4.05 vs. FSMVX (-6.47). FSMVX return over 5 years is better than : 61.60 vs. JVMCX (45.41).
FSMVXJVMCXFSMVX / JVMCX
Total Expense Ratio0.831.8744%
Annual Report Gross Expense Ratio0.831.8844%
Fund Existence24 years14 years-
Gain YTD-5.7382.055-279%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.75B21.5B8%
Annual Yield % from dividends0.910.00-
Returns for 1 year-6.47-4.05160%
Returns for 3 years18.7913.31141%
Returns for 5 years61.6045.41136%
Returns for 10 years18.2425.1872%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBR12.700.30
+2.42%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
VERA22.740.22
+0.98%
Vera Therapeutics
QLYS138.78-1.90
-1.35%
Qualys
RMTI0.94-0.03
-3.27%
Rockwell Medical
STEM0.45-0.04
-7.33%
Stem